17 results
F-3
EX-1.2
CMMB
Chemomab Therapeutics Ltd
16 Oct 23
Shelf registration (foreign)
4:25pm
, as amended, or any other applicable anti-bribery or anti-corruption law (collectively, “Anti-Corruption Laws”), (B) promised, offered, provided, attempted
8-K/A
CMMB
Chemomab Therapeutics Ltd
14 Apr 21
UNAUDITED PRO FORMA Condensed COMBINED FINANCIAL STATEMENTS
11:50am
provisions, or its anti-bribery provisions.
Any of these factors could significantly harm Chemomab’s international expansion and operations and, consequently
8-K
EX-10.1
jrbhj96k
17 Mar 21
Anchiano Announces Shareholder Approval of the Merger with Chemomab and Prices $45.5M Private Financing
12:00am
424B3
hezwnk4fd
12 Feb 21
Prospectus supplement
12:05pm
S-4/A
0j344u4klru
10 Feb 21
Registration of securities issued in business combination transactions (amended)
1:19pm
S-4
n3oy02a4rgd zy8sbks
13 Jan 21
Registration of securities issued in business combination transactions
9:30am
S-4
EX-2.1
7ie31a93zntg1qt
13 Jan 21
Registration of securities issued in business combination transactions
9:30am
8-K
EX-2.1
saf6 kwii
15 Dec 20
Anchiano Therapeutics and Chemomab Announce Entry Into
3:34pm
DEFA14A
EX-2.1
yf7sc
15 Dec 20
Additional proxy soliciting materials
3:32pm
6-K
EX-1.1
vqxgrpg nr24
14 Feb 19
Current report (foreign)
4:40pm
F-1/A
EX-1.1
km4qtihrwkyimcmnv
5 Feb 19
Registration statement (foreign) (amended)
5:30pm
F-1/A
EX-1.1
w6yrqnxd70tl
31 Jan 19
Registration statement (foreign) (amended)
12:00am
F-1
EX-10.5
1mli80m8
7 Jan 19
Registration statement (foreign)
5:11pm
DRS/A
EX-10.5
54zco
27 Nov 18
Draft registration statement (amended)
12:00am
- Prev
- 1
- Next